Skip to main content
Download PDF

Incidental synchronous intrathyroidal parathyroid carcinomas and papillary thyroid microcarcinoma with compressive neck mass and primary hyperparathyroidism: case report and literature review

BMC Endocrine Disorders volume 24, Article number: 125 (2024) Cite this article

Abstract

Background

Parathyroid carcinoma (PC) is a rare malignancy, often diagnosed incidentally through postoperative pathological examination. The occurrence of nodular goiter, intrathyroidal parathyroid carcinoma, contralateral parathyroid adenoma (PA), and papillary thyroid microcarcinoma (PTMC) is extremely uncommon, which prompted us to report our case experience.

Case presentation

We describe a 67-year-old male who presented with a cervical mass causing tracheal compression, which prompted him to seek medical advice. Based on preoperative auxiliary examination results from color Doppler ultrasound, SPECT parathyroid imaging, and blood tests, he was initially diagnosed with a suspected parathyroid adenoma and nodular goiter. Excision of the right lobe and isthmus of the thyroid, and left superior parathyroid gland was conducted, which were sent to intraoperative frozen pathological examination. During intraoperative observation, adhesion around the right thyroid lobe was discovered. Consequently, right central area lymph node dissection was performed due to suspicion of an aggressive malignant tumor. Histology and immunohistochemistry analysis revealed incidental intrathyroidal parathyroid carcinoma, contralateral parathyroid adenoma, classical papillary thyroid microcarcinoma, and nodular goiter.

Conclusion

Parathyroid carcinoma should be highly suspected when extremely high levels of PTH and severe hypercalcemia are present, which cannot be simply explained by a preoperatively localized parathyroid adenoma, especially when suspicious malignant adhesion is found during intraoperative exploration. In cases where multifocal thyroid nodules are associated with increased uptake of 99Tc-sestamibi, the possibility of coexisting carcinomas should be considered, not only for thyroid malignancy but also for the potential presence of intrathyroidal parathyroid carcinoma.

Peer Review reports

Introduction

Parathyroid carcinoma (PC) is a rare endocrine neoplasm, accounting for only 0.005% of all malignancies. It is an uncommon cause of sporadic primary hyperparathyroidism, with the simultaneous occurrence probability being less than 1% [1]. Ectopic parathyroid glands, resulting from aberrant migration during embryogenesis, have an incidence of approximately 16% [2]. The coexistence of synchronous intrathyroidal parathyroid carcinoma, hyperparathyroidism, thyroid carcinoma, and nodular goiter is even rarer.

The management of PC presents challenges in clinical practice, as the diagnosis is mainly established through postoperative histological examination, and clinical manifestations and investigation results often lean towards a diagnosis of parathyroid adenoma. Moreover, intrathyroidal parathyroid carcinoma increases the difficulty of lesion localization. In this report, we describe a case of synchronous multiple intrathyroidal parathyroid carcinoma and provide a literature review to emphasize the diagnostic and treatment challenges from both endocrine and oncology perspectives. The patient provided written informed consent for the publication of this case report.

Case presentation

A 63-year-old male presented with bilateral neck masses, accompanied by xerostomia, polyuria, constipation, and emotional irritability. He was initially diagnosed with hypercalcemia (serum calcium:3.75mmol/L), hyperparathyroidism (parathyroid hormone < PTH>:739pg/ml = 81.29pmol/L), and thyroid mass at a local hospital, where he received fluid infusion, diuresis, and calcitonin for symptomatic treatment. He then sought further treatment at the emergency department of our medical center. Upon admission, laboratory results revealed normal thyroid function but elevated serum calcium levels of 3.10 mmol/L (normal range 2.11–2.52), phosphate levels of 0.55 mmol/L (0.85–1.51), and PTH levels of 67.4 pmol/L (1.60–6.90). The patient experienced anorexia and weight loss since the onset of his illness. His previous medical history, which included kidney stones and bone fractures caused by trauma, drew our attention. However, no kidney disorders were detected, with serum creatinine levels of 90 μmol/L (68–108). There was no known family history of parathyroid disease, thyroid carcinoma, or endocrine neoplasia.

Physical examination revealed a painless, approximately three-centimeter diameter nodule in the right thyroid lobe. Subsequently, imaging examinations were performed to localize and characterize suspicious lesions. Thyroid contrast-enhanced ultrasound (CE-US) suggested the presence of multiple nodular goiter and a parathyroid adenoma located in the middle and lower left thyroid lobe (Fig. 1). 99Tc-sestamibi dual-phase single-photon emission computed tomography (SPECT) revealed a slight uptake signal at the posterior tubercle of the superior left thyroid lobe, with no signals detected in other sites, which appeared to contradict ultrasound findings (Fig. 2). Neck contrast-enhanced computed tomography (CE-CT) demonstrated compression and displacement of the trachea and esophagus to the left by the nodule in the right thyroid lobe (Fig. 3).

Fig. 1
figure 1

Thyroid contrast-enhanced ultrasound (CE-US) images. Multiple nodular goiter (A) and a parathyroid adenoma located in the middle and lower left thyroid lobe (B)

Full size image
Fig. 2
figure 2

Slight uptake signal at the posterior tubercle of the superior left thyroid lobe in 99Tc-sestamibi dual-phase SPECT (A) and parathyroid fusion imaging showed parathyroid adenoma in 15.5 mm*4.3 mm*4.8 mm (B)

Full size image
Fig. 3
figure 3

CE-CT demonstrated compression and displacement of the trachea and esophagus to the left by the nodule in the right thyroid lobe

Full size image

The preoperative diagnosis included primary hyperparathyroidism with suspected left superior parathyroid adenoma, hypercalcemia, right thyroid lobe mass with tracheal compression, and nodular goiter. The initial surgical plan involved excision of the right thyroid lobe and isthmus, as well as left superior parathyroidectomy. The left superior parathyroid was confirmed as a parathyroid adenoma (PA) through intraoperative frozen section analysis. The left inferior parathyroid was normal parathyroid, for a portion of the left inferior parathyroid tissue was sent for intraoperative frozen examination. And we noticed the right superior parathyroid gland in the usual position, but after careful exploration (including within the thymus), no right lower parathyroid gland was found. During neck exploration, adhesions surrounding the right thyroid lobe raised suspicions of malignancy, prompting a right central area lymph node dissection. Multiple nodules were identified in the right thyroid lobe and isthmus; histological examination revealed that both a 2 cm x 2 cm x 1 cm grayish-white solid nodule and a 3 cm x 2 cm x 1 cm cystic nodule as parathyroid carcinoma (PC), with capsular and vascular invasion. Immunohistochemical staining demonstrated positivity for PTH and chromogranin A(CgA) and negativity for thyroid transcription factor-1(TTF-1), thyroglobulin(TG), retinoblastoma gene (Rb) and calcitonin (Fig. 4). The Ki-67 index was 3%. An additional grayish-white nodule measuring 0.4 cm x 0.3 cm x 0.3 cm adjacent to the capsule was identified as incidental classical papillary thyroid carcinoma, while other visible multiple cystic nodules were determined to be nodular goiter, the largest of which measured 1.5 cm x 1.5 cm x 1.2 cm. No cancer metastasis was found in the two lymph nodes dissected from the right central area.

Fig. 4
figure 4

Histology and Immunohistochemical of intrathyroidal parathyroid carcinoma. (4a) The tumor is infiltrative within the thyroid. The expressions of chromogranin A (4b), PTH (4c), and Rb (4d) indicate that the cells originated in the parathyroid gland

Full size image

No severe postoperative complications were observed. Serum calcium levels significantly decreased to 2.29 mmol/L, and PTH levels were reduced to 1.10 pmol/L on the first day after surgery. The patient received appropriate calcium supplementation, resulting in serum calcium levels of 1.90 mmol/L and PTH levels of 1.50 pmol/L at discharge on the third postoperative day. The patient continued oral calcium and calcitriol therapy after hospital discharge. One month after surgery, serum calcium and PTH levels were 1.96 mmol/L and 20.66 pmol/L, respectively, and 2.43 mmol/L and 11.12 pmol/L at three months postoperatively. The most recent measurements, taken six months after surgery, revealed serum calcium levels of 2.35 mmol/L and PTH levels of 8.03 pmol/L. Thyroid function remained normal throughout the perioperative and follow-up periods. No tumor recurrence or postoperative complications occurred during the six-month follow-up period.

Discussion

In our case, four distinct pathologies were identified, including two intrathyroidal parathyroid carcinomas, papillary thyroid microcarcinoma, contralateral parathyroid adenoma, and nodular goiter. We conducted a literature review of the past 20 years, focusing on synchronous intrathyroidal parathyroid carcinomas and incidental papillary thyroid microcarcinoma (PTMC) or parathyroid adenoma (PA), aiming to elucidate the unique relationship and provide management recommendations based on these findings.

Incidental PTMC

The prognosis of papillary thyroid carcinoma (PTC) is excellent, with a 5-year mortality rate of less than 2% [3]. PTMC is characterized as a papillary thyroid carcinoma with a diameter ≤ 1 cm. In recent years, the incidence of PTMC has increased, particularly among patients who undergo surgery for benign thyroid disease. Nodular goiter is the most common benign thyroid disease associated with PTMC [4], which is also observed in our case. Studies have reported that incidentally diagnosed PTMC is less invasive than clinically diagnosed PTMC preoperatively; however, their prognoses are essentially equivalent, and neither impacts the overall survival rate [5, 6].

Intrathyroidal parathyroid tumor

Ectopic parathyroid glands result from aberrant migration during early development, with a prevalence of approximately 2–43%. Inferior parathyroids are more frequently found within the thyroid compared to superior parathyroids [7]. The incidence of intrathyroidal PAs is rare, ranging from 1 to 6%, while the rate of intrathyroidal PC may be even lower, considering the rarity of PC itself (see above). Both conditions present diagnostic challenges that can complicate treatment measures [8].

Initial clinical manifestations of patients with PTC combined with primary hyperparathyroidism (PHPT) can vary, with some being nonspecific, such as asymptomatic neck mass, hypercalcemia with or without symptoms, or fatigue [9], or even normal total serum calcium and PTH levels [10]. Others may experience kidney damage and bone pain [11]. Ultrasonography (US) is typically an effective and economical method for diagnosing thyroid and parathyroid diseases. A previously reported patient presented with fatigue and hyperparathyroidism; US revealed a large, lobulated, solid intrathyroidal nodule consisting of hypoechoic components with microcalcifications and hyperechoic components with vascularity, ultimately confirmed as PTC and ectopic parathyroid adenoma [12].

The concurrent presence of parathyroid adenoma and parathyroid carcinoma is exceedingly rare, and no unique diagnostic criteria exist for reference. A patient with modest hypercalcemia was ultimately diagnosed with both PA and PC, despite remarkably elevated parathormone levels, several times the normal range [13]. Synchronous PC and PA should be considered when a parathyroid lesion is abnormally enlarged and densely adherent to the thyroid lobe, particularly if there is no significant decrease in intraoperative PTH levels following the specific diagnosis and resection of PA [14]. During meticulous exploration of the excised thyroid lobe, normal ectopic parathyroid tissue should be transplanted to prevent permanent hypoparathyroidism [15].

Diagnosis of PC

Parathyroid cancer typically presents in individuals with an average age of 45–51 [16]. Approximately 90% of these cases are active endocrine tumors, while the remainder are non-functional [17], often exhibiting symptoms of compression or invasion of adjacent structures. Preoperative diagnosis of PC is challenging, as its manifestations frequently overlap with those of parathyroid adenoma (PA) or other parathyroid-related hereditary syndromes, such as multiple endocrine tumor syndrome (MEN) or hyperparathyroidism-jaw tumors syndrome (HPT-JT). Fine-needle aspiration (FNA) is not recommended for suspicious PC cases due to the risk of tumor implantation and metastasis along the needle track. The diagnosis of PC should be considered under the following conditions [18]: (a) serum calcium > 14 mg/dL; (b) serum PTH level 10 times higher than normal; (c) rapid onset of acute symptoms; (d) detection of metastasis on radiographic examination.

Despite advances in various imaging techniques, such as 18-fluorocholine positron emission tomography/computed tomography (18 F-PET/CT), PET/magnetic resonance imaging (PET/MRI), and four-dimensional CT (4D-CT), the classic combination of 99mTc-MIBI single-photon emission computed tomography/computed tomography (SPECT/CT) and cervical ultrasonography (cUS) remains the first choice for imaging examinations [2]. In cUS, PC exhibits the following characteristics: relatively larger size (i.e., > 3 cm), inhomogeneous structure, thick capsule, lobulated or irregular borders, suspicious vascularity and calcification, and signs of local invasion [19,20,21]. However, these features may not always be classical or specific. Most parathyroid carcinomas are suspected intraoperatively and definitively diagnosed postoperatively, often without distinctive preoperative signs. In our case, the auxiliary imaging examination results were contradictory: CE-US identified a parathyroid adenoma in the middle and lower left thyroid lobe, while 99Tc-sestamibi SPECT localized the lesion to the posterior tubercle of the superior left lobe of the thyroid. Postoperative histopathology is considered the gold standard for diagnosis, but it is limited by the availability of postoperative pathological specimens. Therefore, it is crucial to maintain a high suspicion for PC.

Additionally, immunohistochemical biomarkers, especially the Ki67 index, can enhance the accuracy of diagnosing atypical parathyroid neoplasms [22]. Parafibromin, coded by the Cell Division Cycle 73 (CDC73) gene, induces cell cycle arrest by inhibiting cyclin D1. PTH expression is almost exclusive to parathyroid tissues rather than thyroid tissue, facilitating the differential diagnosis of the histological origin of the tumor. Moreover, positive expression of CgA and CD44, negative expression of TTF-1 and adenomatous polyposis coli (APC) protein, overexpression of cyclin D1, and reduced p27 protein expression all support a PC diagnosis [23].

It is also worth mentioning that intraoperative PTH (ioPTH) determination can assist surgeons in determining whether to accurately remove target parathyroid gland with abnormally high secretion during surgery. According to the Miami criterion or Vienna criterion, the significant reduction of ioPTH eliminates the need to continue searching for other highly functional tissues during intraoperative neck exploration, which is particularly recommended in multiglandular diseases [24, 25]. However, some experts consider ioPTH monitoring is not necessary, for the false-negative results, false-positive results, surgical efficiency, medical cost burden, etc [26]. What’s more, in a recent prospective study, probe-based near-infrared autofluorescence has been proved a valuable intraoperative auxiliary tool in parathyroid gland identification [27].

Management of PC

Parathyroid carcinoma is a malignant tumor characterized by a high degree of invasion. Its pathological features include invasion of adjacent anatomical tissues, vascular and lymphatic systems, intraneural infiltration, and even distant metastasis. If malignant characteristics are observed during neck exploration, care should be taken to ensure the complete removal of suspicious lesions while preserving tumor encapsulation. The detection of PC often relies on intraoperative observation, and surgical decision-making significantly influences prognosis. In our case, for instance, the presence of dense adhesions in the right thyroid lobe during surgery raised suspicions, prompting the consideration of an invasive manifestation of a malignant tumor originating from the thyroid or parathyroid. The decision to perform en-bloc resection avoided the need for a second surgery. A brief summary of recent management strategies for PC coexisting with PTC is presented in Table 1.

Table 1 Features and surgical management of patients with parathyroid carcinoma and papillary thyroid carcinoma
Full size table

Complete surgical resection is the gold standard for curing PC, which entails total tumor resection, ipsilateral thyroidectomy, and central neck dissection [28, 29]. If intraoperative observation reveals abnormal invasion behavior of suspicious nodules into surrounding tissue structures, the resection of the invaded thyroid and adherent tissue is necessary [30], regardless of whether the concern is a malignant thyroid tumor or a malignant parathyroid tumor. In cases of persistent postoperative symptoms, the possibility of PTH secretion by metastatic parathyroid carcinoma should be considered [18].

If postoperative pathological confirmation indicates that the initial surgical intervention was insufficient, timely additional surgery should be pursued to maximize the chance of healing [31]. The treatment of lymph nodes remains controversial; some advocate for the routine dissection of ipsilateral central lymph nodes as a preventive measure, while others argue that intervention is necessary only if lymph node involvement is identified [32].

Cases where patients refuse surgery or resection margins are positive during the initial operation, radiotherapy may serve as an alternative therapeutic approach. Radiotherapy is essential for reducing the risk of local recurrence [33] and increasing disease-free survival [34]. Other treatment options include the calcimimetic drug cinacalcet and bisphosphonates, which can benefit patients with hypercalcemia as first-line treatments. Denosumab may stabilize calcium levels in cases of refractory hypercalcemia caused by parathyroid carcinoma [35].

Long-term prognosis for PC patients who undergo surgery remains poorly documented. However, it is evident that en-bloc resection with cancer-free resection margins during the initial operation is crucial for ensuring an excellent survival rate. Ten-year overall survival is estimated at 60–70%, as the tumor typically exhibits relatively slow growth [32]. Despite the rarity of intrathyroidal PC or the suspicion of invasive biological behavior of malignant carcinoma during intraoperative observation, surgeons must remain vigilant for the possibility of intrathyroidal PC and carefully examine the specimen to ensure negative margins. In our case, the patient experienced a successful recovery without complications or discomfort during the six-month follow-up period. Prognosis-related research has shown that, compared to en-bloc resection, conservative local excision results in a 3.5-fold higher risk of positive margins and a 6.4-fold higher risk of in situ recurrence [36]. Patients with recurrence require reoperation, which presents challenges in identifying and separating tissues and an increased risk of complications due to postoperative adhesion or metastasis. When distant organ metastases occur, such as in the liver, radiofrequency ablation, resection of liver metastases, or segmental hepatectomy can significantly improve symptoms.

Conclusion

In summary, we have presented a case involving PTMC, ectopic parathyroid carcinoma, and multiple nodular goiter in the right thyroid lobe, coexisting with a left-sided parathyroid adenoma. A literature review was conducted, emphasizing the challenging difficulties in the diagnostic workup and surgical management of PC. Preoperative examination results, to some extent, serve as a reference; however, surgeons must make flexible decisions based on intraoperative findings. Dense adhesions may suggest the presence of malignant thyroid tumors or parathyroid carcinoma, necessitating cautious handling to prevent incomplete resection, rapid recurrence, or secondary surgery following pathological diagnosis, which can impact patients’ quality of life.

The presence of ectopic parathyroid glands and synchronous PA adds to the complexity of preoperative diagnosis for PC. In cases with suspicious thyroid nodules or parathyroid glands, and markedly elevated parathyroid hormone and serum calcium levels, the coexistence of PC should be considered. Immunohistochemistry and molecular studies are advantageous for classifying parathyroid tumors. Because of the highly invasive tendency of PC, it is crucial to perform complete resection as early as possible to prevent metastasis to lymph nodes, adjacent structures, and distant organs.

Data availability

Data will be made available on request.

References

  1. Cetani F, Pardi E, Marcocci C. Update on parathyroid carcinoma. J Endocrinol Invest. 2016;39:595–606.

    Article  CAS  PubMed  Google Scholar 

  2. Petranović Ovčariček P, Giovanella L, Carrió Gasset I, Hindié E, Huellner MW, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48:2801–22.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, et al. Papillary thyroid cancer: genetic alterations and molecular biomarker investigations. Int J Med Sci. 2019;16:450–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. de Carlos J, Ernaga A, Irigaray A, Pineda JJ, Echegoyen A, et al. Incidentally discovered papillary thyroid microcarcinoma in patients undergoing thyroid surgery for benign disease. Endocrine. 2022;77:325–32.

    Article  PubMed  Google Scholar 

  5. Gorostis S, Raguin T, Schneegans O, Takeda C, Debry C. Incidental thyroid papillary microcarcinoma: survival and follow-up. Laryngoscope. 2019;129:1722–6.

    Article  PubMed  Google Scholar 

  6. Ruiz J, Ríos A, Rodríguez JM, Paredes M, Soriano V, et al. Incidental versus clinical diagnosis of papillary thyroid microcarcinoma. Long-term prognosis. Endocrinol Diabetes Nutr (Engl Ed). 2020;67:317–25.

    PubMed  Google Scholar 

  7. Noussios G, Anagnostis P, Natsis K. Ectopic parathyroid glands and their anatomical, clinical and surgical implications. Exp Clin Endocrinol Diabetes. 2012;120:604–10.

    Article  CAS  PubMed  Google Scholar 

  8. Papanikolaou A, Katsamakas M, Boudina M, Pamporaki C, Intzidis I, et al. Intrathyroidal parathyroid adenoma mimicking thyroid cancer. Endocr J. 2020;67:639–43.

    Article  PubMed  Google Scholar 

  9. Xu J-L, Dong S, Sun L-L, Zhu J-X, Liu J. Multiple endocrine neoplasia type 1 combined with thyroid neoplasm: a case report and review of literatures. World J Clin Cases. 2022;10:1032–40.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Alghamdi MA, Alsaif A, Altwijri AS, Alsaif FA, Alsunitan RI, et al. Synchronous incidental double parathyroid adenomas and papillary thyroid carcinoma: a case report with literature review. Niger J Clin Pract. 2021;24:954–63.

    Article  CAS  PubMed  Google Scholar 

  11. Liu W, Huang J-M, Guan M-C, Xie P. Hyperparathyroidism caused by coexisting parathyroid hyperplasia and unilateral bifocal parathyroid carcinoma. Clin Nucl Med. 2022;47:985–8.

    Article  PubMed  Google Scholar 

  12. Guneyli S, Kabaalioglu A, Altinmakas E, Cil BE, Taskin OC, et al. An intrathyroidal nodule consisting of papillary thyroid cancer and ectopic hyperechoic parathyroid adenoma: a case report. Med Ultrason. 2022;24:242–4.

    Article  PubMed  Google Scholar 

  13. Shapiro DM, Recant W, Hemmati M, Mazzone T, Evans RH. Synchronous occurrence of parathyroid carcinoma and adenoma in an elderly woman. Surgery. 1989;106:929–33.

    CAS  PubMed  Google Scholar 

  14. D’Cruz RT, Seet JE, Parameswaran R. Synchronous symptomatic parathyroid carcinoma and parathyroid adenoma with incidental follicular thyroid carcinoma. Ann R Coll Surg Engl. 2020;102:e192–5.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Chen J, Wan Y, Chen S. Rare concurrence of ectopic intrathyroidal parathyroid gland and papillary thyroid carcinoma within a thyroid lobe: a care-compliant case report. Med (Baltim). 2019;98:e16893.

    Article  Google Scholar 

  16. Ferraro V, Sgaramella LI, Di Meo G, Prete FP, Logoluso F, et al. Current concepts in parathyroid carcinoma: a single centre experience. BMC Endocr Disord. 2019;19:46.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Gao WC, Ruan CP, Zhang JC, Liu HM, Xu XY, et al. Wang, nonfunctional parathyroid carcinoma. J Cancer Res Clin Oncol. 2010;136:969–74.

    Article  PubMed  Google Scholar 

  18. De Falco N, Santangelo G, Chirico F, Cangiano A, Sommella MG. Synchronous intrathyroidal parathyroid carcinoma and thyroid carcinoma: case report and review of the literature. BMC Endocr Disord. 2021;21:60.

  19. Machado NN, Wilhelm SM. Parathyroid cancer: a review. Cancers (Basel). 2019;11.

  20. Simescu R, Pop M, Piciu A, Muntean V, Piciu D. Association of parathyroid and differentiated thyroid carcinomas: a narrative up-to-date review of the literature. Med (Kaunas). 2022;58.

  21. Salcuni AS, Cetani F, Guarnieri V, Nicastro V, Romagnoli E, et al. Parathyroid carcinoma. Best Pract Res Clin Endocrinol Metab. 2018;32:877–89.

    Article  CAS  PubMed  Google Scholar 

  22. Erickson LA, Mete O, Juhlin CC, Perren A, Gill AJ. Overview of the 2022 WHO classification of parathyroid tumors. Endocr Pathol. 2022;33:64–9.

    Article  PubMed  Google Scholar 

  23. Uljanovs R, Sinkarevs S, Strumfs B, Vidusa L, Merkurjeva K et al. Immunohistochemical profile of parathyroid tumours: a comprehensive review. Int J Mol Sci. 2022;23.

  24. Irvin GL, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg. 2004;28(12):1287–92.

    Article  PubMed  Google Scholar 

  25. Hargitai L, Bereuter CM, Dunkler D, Geroldinger A, Scheuba C, Niederle B, Riss P. The value of intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism and varying baseline parathyroid hormone levels. BJS Open. 2022;6(6).

  26. Perrier N, Lang BH, Farias LCB, Poch LL, Sywak M, Almquist M, Vriens MR, Yeh MW, Shariq O, Duh Q-Y, Yeh R, Vu T, LiVolsi V, Sitges-Serra A. Surgical aspects of primary hyperparathyroidism. J Bone Min Res. 2022;37(11):2373–90.

    Article  Google Scholar 

  27. Kiernan CM, Thomas G, Patel A, Fan R, Ye F, Willmon PA, Solórzano CC. Does the use of probe-based near-infrared autofluorescence parathyroid detection benefit parathyroidectomy? A randomized single-center clinical trial. Ann Surg. 2023;278(4):549–58.

    Article  PubMed  Google Scholar 

  28. Schulte KM, Talat N, Galata G, Gilbert J, Miell J, et al. Oncologic resection achieving r0 margins improves disease-free survival in parathyroid cancer. Ann Surg Oncol. 2014;21:1891–7.

    Article  CAS  PubMed  Google Scholar 

  29. Lam-Chung CE, Rodríguez-Orihuela DL, Anda González JD, Gamboa-Domínguez A. An unusual simultaneous existence of parathyroid carcinoma and papillary thyroid carcinoma: case report and review of literature. Case Rep Endocrinol. 2020;2128093.

  30. Otake K, Kondo Y, Tsukamoto K, Kurahashi T, Sato K, et al. Parathyroid carcinoma detected within the thyroid. Nagoya J Med Sci. 2021;83:367–74.

    PubMed  PubMed Central  Google Scholar 

  31. Xue S, Chen H, Lv C, Shen X, Ding J, et al. Preoperative diagnosis and prognosis in 40 parathyroid carcinoma patients. Clin Endocrinol (Oxf). 2016;85:29–36.

    Article  PubMed  Google Scholar 

  32. Rodrigo JP, Hernandez-Prera JC, Randolph GW, Zafereo ME, Hartl DM, et al. Parathyroid cancer: an update. Cancer Treat Rev. 2020;86:102012.

    Article  CAS  PubMed  Google Scholar 

  33. Benali K, Aarab J, Benmessaoud H, Nourreddine A, Majjaoui SE, et al. Intrathyroidal parathyroid carcinoma: a case report and literature review. Radiat Oncol J. 2021;39:145–51.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Apaydın T, Yavuz DG. Seven cases of parathyroid carcinoma and review of the literature. Horm (Athens). 2021;20:189–95.

    Article  Google Scholar 

  35. Roukain A, Alwan H, Bongiovanni M, Sykiotis GP, Kopp PA. Denosumab for the treatment of hypercalcemia in a patient with parathyroid carcinoma: a case report. Front Endocrinol (Lausanne). 2021;12794988.

  36. Schulte K-M, Talat N, Galatá G. Margin free resection achieves excellent long term outcomes in parathyroid cancer. Cancers (Basel). 2022;15.

  37. Ben Nacef I, Khelifi D, Kalthoum M, Rojbi I, Riahi I et al. Synchronous parathyroid carcinoma and papillary thyroid carcinoma. Clin Case Rep. 2022;10e06369.

  38. Daniel H, Pillutla P, Schwartz C, Nguyen T. Intrathyroidal parathyroid carcinoma: case report and literature review. Ear Nose Throat J. 2022;9:1455613221093729.

    Google Scholar 

  39. De Falco N, Santangelo G, Chirico F, Cangiano A, Sommella MG. Synchronous intrathyroidal parathyroid carcinoma and thyroid carcinoma: case report and review of the literature. BMC Endocr Disord. 2021;21:60.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Foppiani L, Sola S, Pitto F, Ansaldo G, Piccardo A. A collision intrathyroidal tumor causing primary hyperparathyroidism: evidence from an 18F-Choline PET/CT study. Clin Nucl Med. 2021;46:924–6.

    Article  PubMed  Google Scholar 

  41. Lam-Chung CE, Rodríguez-Orihuela DL, Anda González J, Gamboa-Domínguez A. An unusual simultaneous existence of parathyroid carcinoma and papillary thyroid carcinoma: case report and review of literature. Case Rep Endocrinol. 2020;2128093.

  42. Poortmans N, Verfaillie G, Unuane D, Raeymaeckers S, Lamote J. Intrathyroidal parathyroid carcinoma presenting as an asymptomatic hypercalcemia: a case report. Acta Chir Belg. 2020;120:433–6.

    Article  PubMed  Google Scholar 

  43. Edafe O, Debono M, Tahir F, Balasubramanian SP. Simultaneous presentation of parathyroid carcinoma, papillary thyroid cancer and ACTH-independent hypercortisolism due to benign cortical adenoma. BMJ Case Rep. 2019;12:e230438.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Alharbi N, Asa SL, Szybowska M, Kim RH, Ezzat S. Intrathyroidal parathyroid carcinoma: an atypical thyroid lesion. Front Endocrinol (Lausanne). 2018;9:641.

    Article  PubMed  Google Scholar 

  45. Balakrishnan M, George SA, Rajab SH, Francis IM, Kapila K. Cytological challenges in the diagnosis of intrathyroidal parathyroid carcinoma: a case report and review of literature. Diagn Cytopathol. 2018;46:47–52.

    Article  PubMed  Google Scholar 

  46. Dikmen K, Bostanci H, Gobut H, Yildiz A, Ertunc O, et al. Nonfunctional double parathyroid carcinoma with incidental thyroid micropapillary carcinoma: a rare case. Pan Afr Med J. 2017;27:241.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Baek CO, Kim KH, Song SK. Synchronous parathyroid carcinoma and papillary thyroid carcinoma in a patient with long-standing schizophrenia. Korean J Intern Med. 2017;32:1104–7.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Campennì A, Giovinazzo S, Pignata SA, Di Mauro F, Santoro D, et al. Association of parathyroid carcinoma and thyroid disorders: a clinical review. Endocrine. 2017;56:19–26.

    Article  PubMed  Google Scholar 

  49. Chaychi L, Belbruno K, Golding A, Memoli V. Unusual manifestation of parathyroid carcinoma in the setting of papillary thyroid cancer. Endocr Pract. 2010;16:664–8.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors also thank the patient included in this case report.

Funding

This work was supported by the Sichuan University West China Hospital Discipline Excellence Development 1 · 3 · 5 Project (No. ZYJC21033).

Author information

Author notes

  1. Tianfeng Xu and Xun Zheng contributed equally to this work.

Authors and Affiliations

  1. Division of Thyroid Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Wuhou District, Chengdu, Sichuan Province, China

    Tianfeng Xu, Xun Zheng & Tao Wei

Authors
  1. Tianfeng Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xun Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tao Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XTF analyzed and interpreted the patient data regarding the intrathyroidal parathyroid carcinomas and papillary thyroid microcarcinoma. Writing – original draft: XTF, Writing – review & editing: ZX and WT. WT and ZX performed the surgery. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Tao Wei.

Ethics declarations

Ethics approval and consent to participate

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Clinical Research Ethics Committee of West China Hospital of Sichuan University (2022 − 1743). Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article. The editorial office may request copies of the informed consent documentation upon submission of the manuscript.

Consent for publication

Written informed consent was obtained from the individual for the publication of any potentially identifiable images or data included in this article.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, T., Zheng, X. & Wei, T. Incidental synchronous intrathyroidal parathyroid carcinomas and papillary thyroid microcarcinoma with compressive neck mass and primary hyperparathyroidism: case report and literature review. BMC Endocr Disord 24, 125 (2024). https://doi.org/10.1186/s12902-024-01656-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12902-024-01656-8

Keywords

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us